Inventor · disambiguated record
Tom Van Dooren
Also filed as: VAN DOOREN TOM · VAN DOOREN TOM FRANCOIS L · VAN DOOREN TOM FRANÇOIS L
9 granted patents·1 pending application·33 citations·filing 2008–2022
82Inventor score
Top patents by PatentIndex Score
10 records- 0193US10117850B2Indole amide derivatives and related compounds for use in the treatment of neurodegenerative diseasesUNIV LEUVEN KATH·Filed 2016·Granted Nov 6, 2018·21 cites·19 claims
- 0280US9266832B2Compounds for the treatment of neurodegenerative diseasesGRIFFIOEN GERARD·Filed 2011·Granted Feb 23, 2016·8 cites·14 claims
- 0375US8618138B2Indole amide derivatives and related compounds for use in the treatment of neurodegenerative diseasesGRIFFIOEN GERARD·Filed 2010·Granted Dec 31, 2013·3 cites·18 claims
- 0469US9434722B2Indole amide derivatives and related compounds for use in the treatment of neurodegenerative diseasesUNIV LEUVEN KATH·Filed 2013·Granted Sep 6, 2016·1 cites·20 claims
- 0567US11939324B2Compounds for the treatment of epilepsy, neurodegenerative disorders and other CNS disordersREMYND N V·Filed 2022·Granted Mar 26, 2024·0 cites·12 claims
- 0658US2019054068A1Indole Amide Derivatives and Related Compounds for Use in the Treatment of Neurodegenerative DiseasesUNIV LEUVEN KATH·Filed 2018·Application pending·0 cites
- 0750US11548881B2Compounds for the treatment of epilepsy, neurodegenerative disorders and other CNS disordersREMYND N V·Filed 2018·Granted Jan 10, 2023·0 cites·12 claims
- 0847US8541406B2Thiadiazole derivatives for the treatment of neurodegenerative diseasesGRIFFIOEN GERARD·Filed 2008·Granted Sep 24, 2013·0 cites·28 claims
- 0938US12178805B2Inhibitors of PDE6Delta for use in the prevention and/or treatment of epilepsy and/or neurodegenerative disordersREMYND N V·Filed 2018·Granted Dec 31, 2024·0 cites·10 claims
- 1034US9284271B2Compounds for the treatment of neurodegenerative diseasesGRIFFIOEN GERARD·Filed 2011·Granted Mar 15, 2016·0 cites·13 claims
Join the waitlist — get patent alerts
Get an alert when Tom Van Dooren files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →